Smartleaf Asset Management’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.45K Hold
64
﹤0.01% 3023
2026
Q1
$1.64K Sell
64
-4
-6% -$113 ﹤0.01% 3011
2025
Q4
$2.14K Buy
+68
New +$2.25K ﹤0.01% 2970
2025
Q2
Sell
-182
Closed -$10.9K 2917
2025
Q1
$10.9K Hold
182
﹤0.01% 1894
2024
Q4
$14.7K Hold
182
﹤0.01% 1821
2024
Q3
$14.5K Hold
182
﹤0.01% 1533
2024
Q2
$10.9K Hold
182
﹤0.01% 1368
2024
Q1
$8.89K Hold
182
﹤0.01% 1040
2023
Q4
$7.82K Buy
+182
New +$6.2K ﹤0.01% 802

Other funds holding PRCT

Smartleaf Asset Management's PRCT Position: Q2 2026 in Review

Smartleaf Asset Management held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 64 shares worth $1.45K. The position accounts for ﹤0.01% of the portfolio, ranked #3023.

Smartleaf Asset Management first reported a position in PRCT in Q4 2023 and has held it in 9 quarters since. The position peaked at $14.7K in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Smartleaf Asset Management held 64 shares of Procept Biorobotics worth $1.45K as of Q2 2026.
  • Smartleaf Asset Management left its Procept Biorobotics share count unchanged in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #3023 holding.
  • Smartleaf Asset Management first reported a position in Procept Biorobotics in Q4 2023 and has held it in 9 quarters since.
  • Smartleaf Asset Management's Procept Biorobotics position peaked at $14.7K in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.